×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
The Importance of Country Selection in Clinical Study Design
Session Chair(s)
Joan Meyer
Covance, United States
The importance of country selection as part of the overall clinical trial strategy will be discussed. The impact of country selection on patient recruitment and retention programs and how it impacts a company’s marketing plans will be considered.
Learning Objective : Discuss the importance of country selection in clinical study strategy and design; Describe the impact of country selection on patient recruitment and retention plans; Recognize the importance of proactively leveraging country selection to support marketing plan objectives.
Speaker(s)
Country-specific Differences in Data Quality and Clinical Grants Costs
Jeffrey S. Handen, PhD
Medidata Solutions Worldwide, United States
Vice President, Clinical Solutions
Panelist
Lani Hashimoto
Novartis Pharmaceuticals Corporation, United States
Associate Director, Patient Engagement